Ronald Dollens, the former president and CEO of Guidant Corp., is walking away from his board seat at Abiomed Inc. (NSDQ:ABMD) with one year left on his term, according to documents filed with the federal Securities & Exchange Commission.
Dollens, who joined the board of the Danvers, Mass.-based heart pump maker in 2006, was set to have his board term expire in 2011, but evidently decided to step down before his term expired.
Abiomed officials did not release a statement regarding his resignation, except for the single-sentence filing that said Dollens resigned his seat on August 25 “effective immediately.”
The company held its annual shareholders meeting August 11, where CEO Michael Minogue and directors Gerald Austen and Martin Sutter were all re-elected to three-year terms.
An industry veteran with years of experience leading medical device firms, Dollens, 63, served on the company’s compensation committee. He also serves as non-executive chairman for San Antonio-based wound care products maker Kinetic Concepts Inc. (NYSE:KCI).
A spokeswoman at KCI told MassDevice that Dollens has not resigned his seat with the company.